Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
Vitestro
Vitestro Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
Do published findings about Vitestro match what happens in practice?
Public evidence
FDA Authorizes Autonomous Blood-Drawing Robot
Forbes Healthcare
Public evidence
Vitestro secures FDA nod for robotic blood draw device
MedTech Dive
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
What we still don’t know
Nobody has answered these yet. Your experience can help us understand what is happening.
Matters of record
Settled elsewhere. Context for reading the above, not something practice can confirm.
- 2 public external signal(s) across 2 source(s).Recorded by HealthAratus
Tool intelligence
What HealthAratus understands
HealthAratus currently understands Vitestro through regulatory records and external market activity.
- Category
- imaging_diagnostics
What HealthAratus is still learning
HealthAratus is beginning to understand Vitestro. As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
What this is built on
The material the questions above were built from, with its attribution.
Vitestro is an autonomous robotic device that performs blood draws. It uses ultrasound imaging and robotics to automate the venipuncture process.
Stated capabilities
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
The device autonomously performs the entire blood draw process, including tourniquet application and bandaging.
According to Vitestro
Does this change your workflow?
Independent and public evidence
Found in public sources. Not a clinician’s experience, and never presented as one.
Recent change
Vitestro secures FDA nod for robotic blood draw device
According to MedTech Dive
Have you noticed this shift?
Recent change
FDA Authorizes Autonomous Blood-Drawing Robot
According to Forbes Healthcare
A matter of record — context, not something practice can confirm.
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
What it does
• Aletta® is Vitestro's Autonomous Robotic Phlebotomy Device™, designed to automate venipuncture with precision and efficiency. Utilizing AI-guided ultrasound imaging and robotic needle insertion, Aletta® enhances blood collection accuracy and patient comfort. The device autonomously performs the entire blood draw…
Vendor & external product information, not independently verified by HealthAratus
Where it's used
Deployed in hospital settings, Europe, United States (pending FDA approval)
Key strength
Regulatory: CE-marked in Europe, FDA approval pending
Key capabilities
AI-powered Doppler ultrasound for precise vein identification, Robotic-controlled needle insertion ensuring consistent blood draws, Fully automated blood collection process reducing human dependence
Clinical use cases
Routine blood draws in hospital settings, High-volume outpatient blood collection centers, Patients with difficult venous access
Who uses it
Hospitals and clinical laboratories, Phlebotomists and nursing staff, Patients undergoing routine blood collection
How the reality here has changed
Not enough recorded activity across time yet to describe how the reality here has moved. As accounts of Vitestro accumulate, this becomes a record of how the reality moved rather than a snapshot of one moment.
Connected intelligence
Category intelligence